Competition authority approves Meda's acquisition of Recip


Competition authority approves Meda's acquisition of Recip

The Swedish Competition Authority has announced that nothing hinders Meda from
acquiring Recip AB. The acquisition will be completed within short.

For more information, please contact:

Anders Larnholt, Investor Relations, tel.+46 709 458 878

MEDA AB (publ) is an international specialty pharma company that concentrates on
marketing and market-adapted product development. Acquisitions and long-term
partnerships are fundamental factors that drive the company's strategy. Meda is
represented with own organisations in 26 countries and with more than 1 500
employees within marketing and sales. Meda's products are sold in approximately
120 countries world-wide. The Meda share is listed under Large Cap on the OMX
Nordic Stock Exchange. Find out more, visit www.meda.se.

Attachments

12072276.pdf